ProfileGDS5822 / ILMN_2754155
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 66% 78% 72% 68% 76% 70% 64% 65% 65% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 136.366
GSM1276600PDAC Late Ablation Control 2117.778
GSM1276601PDAC Late Ablation Control 39372
GSM1276602PDAC Late Ablation 141.768
GSM1276603PDAC Late Ablation 2102.376
GSM1276604PDAC Late Ablation 360.570
GSM1303940PDAC Late Ablation_anti-CTLA4 133.664
GSM1303941PDAC Late Ablation_anti-CTLA4 248.365
GSM1303942PDAC Late Ablation_anti-CTLA4 35065